Patient Dies After Experimental Cell Therapy in Bristol Myers Squibb Study
Bristol Myers Squibb said a patient in its multiple sclerosis study died after receiving the experimental cell therapy. The patient developed movement-related problems after the infusion and died 44 days later. BMY shares fell 2.4%.